Grab shares dropped another 9% in morning trading<blockquote>Grab股价早盘再下跌9%</blockquote>
Grab shares dropped another 9% in morning trading after falling more than 9% yesterday.
RK888
IP属地：未知
- LikeUS to Opec+: ‘This isn’t the end’ of effort to ease oil prices<blockquote>美国对欧佩克+：缓解油价努力的“这还不是结束”</blockquote>
US to Opec+: ‘This isn’t the end’ of effort to ease oil prices<blockquote>美国对欧佩克+：缓解油价努力的“这还不是结束”</blockquote>
Biden wants the cartel to pump more oil to bring down prices and keep the post-Covid economic recovery on course - OkayU.S. Daylight Saving Time Ends on Sunday, Nov.7 2021<blockquote>美国夏令时将于2021年11月7日星期日结束</blockquote>
U.S. Daylight Saving Time Ends on Sunday, Nov.7 2021<blockquote>美国夏令时将于2021年11月7日星期日结束</blockquote>
Dear Tigers, U.S. Daylight Saving Time Ends on Sunday, Nov.7 2021,at 2:00 a.m. At that time,the regu - 👏Warren Buffett says this is the best type of business to own when inflation spikes — in other words, what you should buy right now<blockquote>沃伦·巴菲特表示，这是通胀飙升时拥有的最佳企业类型——换句话说，你现在应该购买什么</blockquote>
Warren Buffett says this is the best type of business to own when inflation spikes — in other words, what you should buy right now<blockquote>沃伦·巴菲特表示，这是通胀飙升时拥有的最佳企业类型——换句话说，你现在应该购买什么</blockquote>
Inflation is high. You might as well profit from it.High inflation rates in the country have become a serious concern on Wall Street.But fortunately for everyday investors, Berkshire Hathaway chief Warren Buffett has plenty of experience in navigating such an environment.Buffett managed a stock portfolio through periods of double-digit inflation rates in the 1970s and has plenty of advice on what to own when consumer prices spike.In a 1981 letter to Berkshire shareholders, Buffett highlighted tw - GreatEntrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share<blockquote>Entrada在早盘交易中上涨了30%以上，高于每股20美元的IPO价格</blockquote>
Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share<blockquote>Entrada在早盘交易中上涨了30%以上，高于每股20美元的IPO价格</blockquote>
Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share.Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.
